Biosynthesis of Oxytetracycline by Streptomyces rimosus: Past, Present and Future Directions in the Development of Tetracycline Antibiotics H Petković, T Lukežič, J Šušković Food technology and biotechnology 55 (1), 3, 2017 | 92 | 2017 |
Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering U Lešnik, T Lukežič, A Podgoršek, J Horvat, T Polak, M Šala, B Jenko, ... Angewandte Chemie International Edition 54 (13), 3937-3940, 2015 | 64 | 2015 |
Dual mechanism of action of the atypical tetracycline chelocardin JJ Stepanek, T Lukežič, I Teichert, H Petković, JE Bandow Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1864 (6), 645-654, 2016 | 55 | 2016 |
Comparison of proteomic responses as global approach to antibiotic mechanism of action elucidation CHR Senges, JJ Stepanek, M Wenzel, N Raatschen, Ü Ay, Y Märtens, ... Antimicrobial agents and chemotherapy 65 (1), 10.1128/aac. 01373-20, 2020 | 43 | 2020 |
Strategies for the discovery and development of new antibiotics from natural products: three case studies J Herrmann, T Lukežič, A Kling, S Baumann, S Hüttel, H Petković, ... How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and …, 2016 | 37 | 2016 |
Identification of the chelocardin biosynthetic gene cluster from Amycolatopsis sulphurea: a platform for producing novel tetracycline antibiotics T Lukežič, U Lešnik, A Podgoršek, J Horvat, T Polak, M Šala, B Jenko, ... Microbiology 159 (Pt_12), 2524-2532, 2013 | 35 | 2013 |
Engineering Atypical Tetracycline Formation in Amycolatopsis sulphurea for the Production of Modified Chelocardin Antibiotics T Lukežič, AA Fayad, C Bader, K Harmrolfs, J Bartuli, S Groß, ... ACS chemical biology 14 (3), 468-477, 2019 | 30 | 2019 |
Hydrodynamic cavitation efficiently inactivates potato virus Y in water A Filipić, T Lukežič, K Bačnik, M Ravnikar, M Ješelnik, T Košir, ... Ultrasonics Sonochemistry 82, 105898, 2022 | 22 | 2022 |
Amidochelocardin overcomes resistance mechanisms exerted on tetracyclines and natural chelocardin F Hennessen, M Miethke, N Zaburannyi, M Loose, T Lukežič, S Bernecker, ... Antibiotics 9 (9), 619, 2020 | 18 | 2020 |
Suskovic, J5434370: Biosynthesis of Oxytetracycline by Streptomyces rimosus: past, present and future directions in the development of tetracycline antibiotics. vol. 55, issue 1 H Petkovic, T Lukezic Food Technol Biotechnol, 3-13, 2017 | 7 | 2017 |
Heterologous expression of the atypical tetracycline chelocardin reveals the full set of genes required for its biosynthesis T Lukežič, Š Pikl, N Zaburannyi, M Remškar, H Petković, R Müller Microbial Cell Factories 19, 1-13, 2020 | 6 | 2020 |
Rapid identification of atypical tetracyclines using tandem mass spectrometric fragmentation patterns M Šala, D Kočar, T Lukežič, G Kosec, M Hodošček, H Petković Rapid Communications in Mass Spectrometry 29 (17), 1556-1562, 2015 | 5 | 2015 |
Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models K Rox, R Jansen, T Lukežič, M Greweling-Pils, J Herrmann, M Miethke, ... Microbiology Spectrum 12 (1), e01289-23, 2024 | 2 | 2024 |
Introduction to interlaboratory comparisons F Petter, C Trontin, G Anthoine, M Ravnikar, T Dreo, T Lukežič, ... Critical Points for the Organisation of Test Performance Studies in …, 2022 | 1 | 2022 |
General Background F Petter, C Trontin, G Anthoine, N Mehle, M Ravnikar, T Dreo, T Lukežič, ... Critical Points for the Organisation of Test Performance Studies in …, 2022 | | 2022 |
Description of the Process of TPS Organisation G Anthoine, I Brittain, AM Chappé, A Chabirand, T Dreo, F Faggioli, ... Critical Points for the Organisation of Test Performance Studies in …, 2022 | | 2022 |
TPS reports with description of the method, materials and software used, as well as the data analysis-Round 2, Version 1.0: grant agreement N. 773139 G Anthoine, I Brittain, A Chabirand, T Dreo, F Faggioli, C Harrison, M Luigi, ... Valitest EU project consortium, 2021 | | 2021 |
Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host R Müller, T Lukezic, M Remskar, N Zaburannyi, C Bader, A Sikandar, ... US Patent App. 16/954,461, 2020 | | 2020 |
Minimum performance parameters to select tests for validation and selection of laboratories for TPS: grant agreement N. 773139, deliverable N° 1.1 Š Alič, G Anthoine, A Chabirand, AM Chappé, T Dreo, L Laurenson, ... | | 2019 |
List of tests for validation: round 1, grant agreement N. 773139 Š Alič, G Anthoine, A Chabirand, AM Chappé, T Dreo, T Jakomin, ... | | 2019 |